Showing 1201-1210 of 1717 results for "".
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31144/Participating in clinical trials presents a valuable opportunity for neurology practices to expand services and enhance revenue streams. Clinical trials are integral to the drug development process, enabling the pharmaceutical industry to assess the safety and efficacy of new neurological treatments
- The Night Shift: Putting Sleep Studies to Work for Youhttps://practicalneurology.com/diseases-diagnoses/sleep/pn0707-sleep-studies-pdf/31153/Enhancing Neurological Diagnoses with Sleep StudiesSleep studies, particularly polysomnography (PSG), are becoming increasingly vital in neurology for accurately diagnosing sleep-related disorders. Despite patients’ reluctance to undergo overnight testing, the objective data obtained from PSGs provi
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0707-movementdisorders-pdf/31157/Psychosis in Parkinson’s Disease: Clinical Insights and ManagementPsychosis is a significant non-motor complication in Parkinson’s disease (PD), impacting approximately one-third of patients. Initially, patients often experience benign visual hallucinations, such as brief, non-threatening images of
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0607-movementdisorder-pdf/31164/Sydenham’s Chorea in Adolescents: Clinical Presentation and ManagementSydenham’s chorea is a critical movement disorder in adolescents, often emerging as a delayed neurological complication of acute rheumatic fever (ARF) following a Group A streptococcal infection. While clinicians might first consi
- Seizures, AEDs and Pregnancy: A Dangerous Combinationhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0407-epilepsy-pdf/31188/Managing epilepsy in women who are pregnant or planning pregnancy presents significant challenges for neurologists. Seizures during pregnancy pose risks to both the mother and the unborn child, while the use of anti-epileptic drugs (AEDs) can lead to congenital malformations and potential cognitive
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31211/Implementing Electronic Medical Records (EMR) in clinical practices represents a significant strategic shift aimed at enhancing provider efficiency and patient safety. In her February 2007 article for *Practical Neurology*, Joyce Peters outlines a comprehensive roadmap for successfully transitioning
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1206Epilepsy-pdf/31237/The Role of Generic Antiepileptic Drugs in Epilepsy ManagementEffective epilepsy treatment aims to achieve seizure freedom without adverse side effects. According to Kwan and Brodie, approximately 64% of patients reach this goal using either monotherapy or a combination of two antiseizure medication
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31247/Recent developments in the treatment of high-grade carotid stenosis have intensified interest in carotid artery stenting (CAS) as an alternative to the traditional carotid endarterectomy (CEA). The FDA has approved CAS for patients with symptomatic carotid stenosis who are deemed high-risk for conve